Physician profile
John Hogg
NPI 1407850209
$8,984.61
in general payments reported to CMS, 2019-2025
14 companies · $541 in 2025
The $541 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $967 · 2020: $311 · 2021: $558 · 2022: $1,927 · 2023: $3,741 · 2024: $939 · 2025: $541.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $2,676 · Food and Beverage: $2,545.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $2,675.90 |
| Food and Beverage | $2,545.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cashflow Solutions, LLC | $2,682.88 | 2023-2024 | Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White, Pcd-52 737a (US) White |
| Medtronic, INC. | $1,364.28 | 2021-2024 | Venaseal |
| Medtronic Vascular, INC. | $1,026.26 | 2019-2020 | |
| Koya Medical, INC. | $952.60 | 2022 | |
| Tactile Systems Technology INC | $935.94 | 2019-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Siemens Medical Solutions USA, INC. | $813.17 | 2022-2024 | Acuson Redwood Diagnostic Ultrasound System, Cios Alpha, Cios Spin |
| Boston Scientific Corporation | $723.54 | 2019-2025 | Varithena Administration Pack |
| Kerecis Limited | $149.99 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Teva Pharmaceuticals USA, INC. | $122.08 | 2019 | |
| Shockwave Medical, INC | $75.45 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Bard Peripheral Vascular, INC. | $53.28 | 2025 | Venclose Maven Catheter |
| Philips North America LLC | $43.86 | 2024 | (Dd1) Duo Hybrid |
| Janssen Pharmaceuticals, INC | $27.11 | 2024 | Xarelto |
| Biocompatibles, INC. | $14.17 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Hogg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.